WholyMe develops and markets 100% organic supplements and topical products aimed at managing chronic pain and muscle and joint health. The company formulates products in-house and manufactures them in Europe. Its first range includes a cannabis-based ointment slated to launch in spring 2020, and products will be sold online. WholyMe also plans partnerships with gym clubs to target athletic millennials and prevent injuries. The founders position the products as having no adverse effects compared with conventional painkillers and as free from synthetics, petroleum and GMOs. The company cites a large addressable market: the natural medicine products market in Europe is worth €16 billion and grew at +7% CAGR from 2017–2023.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2020